English

More about this topic

wellbeing

Obesity rates expected to surge worldwide in coming decades

About six in 10 adults worldwide will be overweight or obese by 2050, according to new projections.

Health news

Obesity drugs could help curb alcohol cravings, study suggests

The new findings add to growing evidence that the medicines could help people with alcohol addiction.

Health news

GLP-1 drug akin to Ozempic showed no benefits for Parkinson’s disease

GLP-1 drugs are being explored as potential treatments for a range of conditions.

Business

Novo Nordisk shares surge as weight loss treatments boost profits

Demand for weight-loss drugs surged throughout 2024, outpacing supply for most of the year. In December, Novo Holdings, an investment foundation of Novo Nordisk, acquired three manufacturing sites in Catalent to expand its production capacity.

ADVERTISEMENT

Healthcare

UK pharmacies urge tougher rules for online sales of weight loss drugs

The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand.

Nutrition

Fizzy water could play a role in aiding weight loss, new study claims

A balanced diet and regular exercise remain the main leverages if you want to lose weight, the researchers noted.

Health news

Scientists unveil benefits and risks of blockbuster weight-loss drugs

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health outcomes.

Business

Novo Nordisk shares plunge on the back of disappointing trial results

Novo Nordisk shares have plunged 20% amid the disappointing trial result of its latest weight-loss drug CagriSema. The fall wiped out €90bn in market valuation on Friday.

Healthcare

Italy unveils plans for €4.2 million fund to target obesity

The creation of the fund is viewed as a small but meaningful step to address Italy’s looming obesity problem but critics remain unconvinced of its impact.

Health news

England to roll out new anti-obesity drug but only for some patients

The drug is expected to cost €381.1 million per year within three years.

Business

Eli Lilly shares rise as Zepbound weight-loss test shows solid success

Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.

Health news

Weight loss drugs could help fight chronic kidney disease, study finds

Researchers said the drugs could make a major difference for chronic kidney disease patients by helping to reduce other risk factors.

Radio Schuman

Why has the EU deforestation law become so politicised?

Germany's national elections are influencing the negotiations of EU deforestation law, which entered interinstitutional negotiations on 21 November, according to campaigner.

Health news

Weight loss yo-yo effect linked to fat cell ‘memory,’ study finds

Fat cells were found to retain a long-lasting "memory" of obesity making it hard to maintain weight loss results.

Health news

Weight-loss drugs like Ozempic may reduce opioid overdose rates

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.

Health news

Teens on anti-obesity drugs less likely to consider or attempt suicide

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged caution in interpreting the results.

Health news

France to patients: Take weight loss drug Wegovy on your own dime

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

Business

Novo Nordisk boss in US grilling over prices for weight-loss drugs

Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.

Health news

Severe obesity is rising in the US, according to new research

The rate of severe obesity is about 40 per cent in the US, with women at particularly high risk of severe obesity, the study found.

Business

Weight loss market: Eli Lilly and Novo Nordisk's rivals muscle in

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up to release their own treatments, aiming to challenge the two industry leaders.